Literature DB >> 1683974

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

E Nava1, R M Palmer, S Moncada.   

Abstract

Hypotension in septic shock is often resistant to treatment with vasoconstrictors and appears to be mediated by production of nitric oxide (NO). Reversal of endotoxin-induced hypotension in rats was achieved by intravenous injection of 30 mg/kg NG-monomethyl-L-arginine (L-NMMA), an inhibitor of endogenous NO synthesis. A lower dose of 3 mg/kg L-NMMA was ineffective, but 300 mg/kg L-NMMA accelerated and enhanced the fall in blood pressure. NO synthase inhibitors may be helpful in the treatment of hypotension associated with sepsis or therapeutic use of cytokines, but complete inhibition of endogenous NO synthesis may be counterproductive.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683974     DOI: 10.1016/0140-6736(91)92375-c

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

Review 1.  The nitric oxide pathway in the cardiovascular system.

Authors:  S Llorens; J Jordán; E Nava
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

2.  Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.

Authors:  D J Lefer; R Scalia; B Campbell; T Nossuli; R Hayward; M Salamon; J Grayson; A M Lefer
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat.

Authors:  N K Boughton-Smith; S M Evans; F Laszlo; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  Exercise-induced pulmonary vasoconstriction during combined blockade of nitric oxide synthase and beta adrenergic receptors.

Authors:  D W Kane; T Tesauro; T Koizumi; R Gupta; J H Newman
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

5.  Pathophysiology of adynamic ileus.

Authors:  J J Cullen; D K Caropreso; L L Hemann; M Hinkhouse; J L Conklin; K S Ephgrave
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

6.  Therapies for sepsis. Emerging therapies for sepsis and septic shock.

Authors:  E Abraham
Journal:  West J Med       Date:  1997-03

7.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Authors:  J A Mitchell; K L Kohlhaas; R Sorrentino; T D Warner; F Murad; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone.

Authors:  R A Star; N Rajora; J Huang; R C Stock; A Catania; J M Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.

Authors:  A Jakubowski; N Maksimovich; R Olszanecki; A Gebska; H Gasser; B K Podesser; S Hallström; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

10.  Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells.

Authors:  N Marczin; T Jilling; A Papapetropoulos; C Go; J D Catravas
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.